Skip to main content Skip to footer

Creating a flexible, intelligent cold chain

July 21, 2022 5-MINUTE READ

rESEARCH rEPORT

In brief

Struggling to scale

70%

of respondents said they lack efficient logistics cold chain capabilities at scale(2).

In 2020, the business of delivering cold chain pharmaceuticals reached $17.2 billion.

Define the vision

 

Evaluate your products and determine what your cold chain will require.

Segment products

 

Identify and prioritize the factors (disease burden, product type, etc.) most pertinent to your business.

Set your north star

 

Assess your product portfolio. ​ Map and further segment the products on the framework(s)​ to discern nuances.

Determine desired capabilities

 

Identify common capabilities across major segments for all frameworks under consideration. 

Implement and continuously improve

 

Acquire agnostic solutions and capabilities that can serve all product segments across a rapidly changing landscape.

Life sciences companies, particularly those who didn’t take part in the COVID-19 vaccine rollout, are acutely aware that their operating models may become uncompetitive in the evolving biopharma landscape.

Right investment, right outcome

Carly Guenther

Managing Director – Strategy & Consulting, Supply Chain & Operations, Customer-Centric Supply Chain Lead

I am passionate about supporting our clients in their Supply Chain & Operations transformations preparing for the new wave of growth.

Gregory Demitrack

Manager – Strategy & Consulting, Life Sciences Supply Chain & Operations

Related capabilities

Supply Chain & Operations Services

Delivering end-to-end supply chain strategy and transformation